A randomised, crossover study of study drug 038 and controlled-release oxycodone HCl tablets in patients with chronic non-cancer pain.

Trial Profile

A randomised, crossover study of study drug 038 and controlled-release oxycodone HCl tablets in patients with chronic non-cancer pain.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2012

At a glance

  • Drugs Opioid analgesics; Oxycodone
  • Indications Pain
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Purdue Pharma
  • Most Recent Events

    • 01 Apr 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 17 Jan 2011 Planned End Date changed from 31 Mar 2011 to 31 Mar 2012 as reported by ISRCTN: Current Controlled Trials.
    • 14 Aug 2010 Planned end date (31 Mar 2011) added as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top